HCA makes CAR T-cell therapy available for myeloma patients

HCA Healthcare UK has introduced Chimeric Antigen Receptor (CAR) T-cell therapy for eligible myeloma patients. The immunotherapy, which harnesses the body’s own immune system to fight blood cancer, will initially be available at HCA at University College Hospital (UCL) before being rolled out to the Christie Private Care in Manchester later this year. HCA first…